Quote | Viracta Therapeutics Inc. (NASDAQ:VIRX)
Last: | $0.49 |
---|---|
Change Percent: | 0.0% |
Open: | $0.51 |
Close: | $0.49 |
High: | $0.55 |
Low: | $0.48 |
Volume: | 106,534 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Viracta Therapeutics Inc. (NASDAQ:VIRX)
2024-06-07 07:22:46 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning! Moving stocks this morning is heavy trading, drug approval, a ...
SAN DIEGO, May 17, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that, in connection with the appointment of Mi...
Message Board Posts | Viracta Therapeutics Inc. (NASDAQ:VIRX)
Subject | By | Source | When |
---|---|---|---|
$VIRX- Took a starter position @ $5.01 today. | AOuvier | investorshub | 11/24/2021 5:53:23 PM |
WOW | TheSilverFox121 | investorshub | 06/25/2021 9:41:45 PM |
Great to see some upwards strength! GLTA | TheSilverFox121 | investorshub | 06/14/2021 3:37:55 PM |
I just bought in at 9.07 GLTA | TheSilverFox121 | investorshub | 03/09/2021 5:11:57 PM |
buy buy buy!!!! | trity | investorshub | 03/01/2021 2:20:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Viracta Therapeutics Inc. Company Name:
VIRX Stock Symbol:
NASDAQ Market:
Viracta Therapeutics Inc. Website:
SAN DIEGO, May 17, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that, in connection with the appointment of Mi...
SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced the appointment of Michael Faerm as Chief Financia...